DiaMedica Therapeutics Competitors and Similar CompaniesClear all
DiaMedica Therapeutics's competitors and similar companies include ZZ Biotech, NeuroPace, BioMarin Pharmaceutical and Livzon Pharmaceutical Group.
 DiaMedica Therapeutics DiaMedica Therapeutics is a biopharmaceutical company which engages in the development of treatments for neurological and kidney diseases. |  ZZ Biotech ZZ Biotech is a company developing biological treatments for ischemic stroke and other neurological diseases. |  NeuroPace NeuroPace is a company that designs, develops, and manufactures implantable devices for the treatment of neurological disorders. |  BioMarin Pharmaceutical BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | |
Founding Date | Founding Date 2000 | Founding Date 2006 | Founding Date 1997 | Founding Date 1997 | Founding Date 1985 |
Type | Type Public | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Minneapolis, US HQ | Locations Houston, US HQ Sydney, AU | Locations Mountain View, US HQ | Locations San Rafael, US HQ Martínez, AR Crows Nest, AU Sao Paulo, BR Bogotá, CO Kronberg Im Taunus, DE Wanchai, HK see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN |
Employees | Employees 26189% increase | Employees 6810% increase | Employees 1712% increase | Employees 3,0015% increase | Employees 9,067 |
Valuation ($) | Valuation ($) 184.7 m | Valuation ($) N/A | Valuation ($) 189.5 m | Valuation ($) 13.3 b | Valuation ($) 4.2 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $100m (FY, 2025) | Revenue (est.) $3.2b (FY, 2025) | Revenue (est.) ¥11.7b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $22.8m (FY, 2025) | Cost of goods $717.4m (FY, 2025) | Cost of goods ¥4.1b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $77.2m (FY, 2025) | Gross profit $2.5b (FY, 2025) | Gross profit ¥7.8b (FY, 2025) |
Net income | Net income ($32.7m) (FY, 2025) | Net income N/A | Net income ($21.5m) (FY, 2025) | Net income $348.9m (FY, 2025) | Net income ¥2.4b (FY, 2025) |
Operating ⚠ | |||||
Patents Issued | Patents Issued N/A | Patents Issued N/A | Patents Issued 132 (FY, 2020) | Patents Issued 1.2 k (FY, 2016) | Patents Issued N/A |
Trademarks | Trademarks N/A | Trademarks N/A | Trademarks 23 (FY, 2020) | Trademarks N/A | Trademarks 45 (Sep, 2023) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 7.9m | Total funding raised $ 208m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ZZ Biotech
HQ
Houston, US
Employees
68↑ 10% increase
ZZ Biotech is a company developing biological treatments for ischemic stroke and other neurological diseases.
View companyNeuroPace
HQ
Mountain View, US
Employees
171↑ 2% increase
NeuroPace is a company that designs, develops, and manufactures implantable devices for the treatment of neurological disorders.
View companyBioMarin Pharmaceutical
HQ
San Rafael, US
Employees
3,001↑ 5% increase
BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company